Table 3.

RCT reports in which affected publications by Sato and colleagues are included in the justification for the trial

RCT	Affected trial report cited	Intervention, patient group and outcome	Sample size	Follow-up
Bauman 200558	6	1 alpha-hydroxyvitamin D2 for reducing bone loss in spinal cord injury patients	40	24 months
Berendsen 201359	14	Vitamins D, B12 and folate for slowing functional decline in people over 65 years	1250	12 months
Binkley 200960	7 10	Vitamin K for bone density and biochemical markers in postmenopausal women	381	12 months
Emaus 201361	7 9 10	Vitamin K for bone density and biochemical markers in postmenopausal women	334	12 months
Grieger 200962	14	Multivitamins for improving bone quality, falls and nutritional status in care home residents	92	6 months
Hermann 200763	14	B-vitamins for bone density and biochemical markers in people with osteoporosis	47	12 months
Rucklidge 201264	14	Multivitamins and minerals for stress in adults	91	2 months
Van Wijngaarden 201465	14	Vitamins B12 and folate for preventing fractures in people ≥65 years with elevated homocysteine status	2919	24 months

RCT, randomised controlled trial.